Clinical Trial Update: Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NT 201 (botulinum toxin) versus placebo for lower limb spasticity due to stroke or traumatic brain injury; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Traumatic Brain Injury

Drugs mentioned

• NT 201 (Botulinum toxin) (Botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury | Phase 3 | Status: ACTIVE_NOT_RECRUITING